(From left): Wuxi AppTec board secretary Chi Yao, chairman Li Ge and CFO Edward Hu, at the company’s press conference to announce its Hong Kong IPO, on Friday. Photo: Edward Wong

Leading Chinese biotech firm Wuxi AppTec says US hurdles will not dim acquisition appetite

  • Wuxi AppTec’s executives say they will fully comply with stringent US requirements as they pursue deals in life sciences and biotech
Topic |   Pharmaceuticals

TOP PICKS

(From left): Wuxi AppTec board secretary Chi Yao, chairman Li Ge and CFO Edward Hu, at the company’s press conference to announce its Hong Kong IPO, on Friday. Photo: Edward Wong
READ FULL ARTICLE